Therakind Ltd

corporate_fareorganization

Country: United Kingdom

Therakind Ltd

- Funding / Projects
  (3)

3 Projects, page 1 of 1

CLOSED (Clonidine for Sedation of Paediatric Patients in the Intensive Care Unit)
Open Access Mandate for Publications assignment_turned_inProject2013 - 2018Partners:IRCCS, ARNAS-Civico, Universitätsklinikum Erlangen, UT, UCL +8 partners
IRCCS,
ARNAS-Civico,
Universitätsklinikum Erlangen,
UT,
UCL,
KI,
VSOP,
ERASMUS MC,
FONDAZIONE GIANNI BENZI ONLUS,
OPBG,
Therakind Ltd,
SERGAS,
Charles University
Funder: European Commission Project Code: 602453
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
ADDUCE (Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects)
Open Access Mandate for Publications assignment_turned_inProject2010 - 2016Partners:KUL, Eunethydis, University of Cagliari, UCC, ISS +11 partners
KUL,
Eunethydis,
University of Cagliari,
UCC,
ISS,
GSTFT,
University of Nottingham,
STICHTING RADBOUD UNIVERSITEIT,
Therakind Ltd,
CIMH,
UKA,
UCL,
University of Southampton,
University of Dundee,
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE,
Vadaskert Alapítvány a Gyermekek Lelki Egészségéért
Funder: European Commission Project Code: 260576
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
NEOVANC (Treatment of late onset bacterial sepsis caused by vancomycin susceptible bacteria in neonates and infants aged under three months)
Open Access Mandate for Publications assignment_turned_inProject2014 - 2020Partners:SERGAS, SYNAPSE RESEARCH MANAGEMENT PARTNERS SL, FONDAZIONE PENTA-FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV-ONLUS, University of Liverpool, Therakind Ltd +9 partners
SERGAS,
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL,
FONDAZIONE PENTA-FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV-ONLUS,
University of Liverpool,
Therakind Ltd,
Aristotle University of Thessaloniki,
CVBF,
SGUL,
University of Edinburgh,
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE,
OPBG,
UT,
IRCCS,
Cardiff University
Funder: European Commission Project Code: 602041
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

Therakind Ltd

Therakind Ltd

3 Projects, page 1 of 1

CLOSED (Clonidine for Sedation of Paediatric Patients in the Intensive Care Unit)

ADDUCE (Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects)

NEOVANC (Treatment of late onset bacterial sepsis caused by vancomycin susceptible bacteria in neonates and infants aged under three months)

Loading